PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10202848-1	1999	Inhibition of angiotensin (Ang) II type 1 (AT1) receptors in various target tissues of adult Sprague-Dawley rats was studied after single oral administration of TCV-116.	candesartan cilexetil	161-168	angiotensin II receptor, type 1a	Rattus norvegicus	43-46	
10202848-3	1999	Four hours after the administration of TCV-116 (1 mg/kg), Ang II-receptor binding was markedly inhibited in the kidney (20% of control), adrenal cortex (27%), thoracic aorta (57%), heart (55%) and testis (76%) where AT1 receptors predominate.	candesartan cilexetil	39-46	angiotensin II receptor, type 1a	Rattus norvegicus	216-219	
10202848-7	1999	These data indicate that orally administered TCV-116 specifically binds to AT1 receptors both in peripheral tissues and the central nervous system.	candesartan cilexetil	45-52	angiotensin II receptor, type 1a	Rattus norvegicus	75-78